P53-induced adipose tissue inflammation is critically involved in the development of insulin resistance in heart failure

Cell Metabolism

Volumn 15, Issue 1, 2012, Pages 51-64

  Shimizu, Ippei ^a   Yoshida, Yohko ^a   Katsuno, Taro ^a   Tateno, Kaoru ^a   Okada, Sho ^a   Moriya, Junji ^a   Yokoyama, Masataka ^a   Nojima, Aika ^a   Ito, Takashi ^a   Zechner, Rudolf ^b   Komuro, Issei ^c   Kobayashi, Yoshio ^a   Minamino, Tohru ^a,d  

^a CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF GRAZ   (Austria)

^c OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^d JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ADIPOSE TISSUE; ADRENERGIC SYSTEM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; DISEASE ASSOCIATION; DOWN REGULATION; HEART DISEASE; HEART FAILURE; HEART FUNCTION; HEART INFARCTION; HEART LEFT VENTRICLE OVERLOAD; INFLAMMATION; INSULIN RESISTANCE; LIPOLYSIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SYSTOLIC DYSFUNCTION; UPREGULATION;

ADIPOSE TISSUE; ANIMALS; CELL LINE; HEART FAILURE; HUMANS; INFLAMMATION; INSULIN RESISTANCE; ISOPROTERENOL; LIPID METABOLISM; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PRESSURE; SYMPATHETIC NERVOUS SYSTEM; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

EID: 84855453214     PISSN: 15504131     EISSN: 19327420     Source Type: Journal    
DOI: 10.1016/j.cmet.2011.12.006     Document Type: Article

References (58)

1. J. Arnlöv, L. Lind, B. Zethelius, B. Andrén, C.N. Hales, B. Vessby, and H. Lithell Several factors associated with the insulin resistance syndrome are predictors of left ventricular systolic dysfunction in a male population after 20 years of follow-up Am. Heart J. 142 2001 720 724 (Pubitemid 32900501)
2. M. Asakawa, H. Takano, T. Nagai, H. Uozumi, H. Hasegawa, N. Kubota, T. Saito, Y. Masuda, T. Kadowaki, and I. Komuro Peroxisome proliferator-activated receptor gamma plays a critical role in inhibition of cardiac hypertrophy in vitro and in vivo Circulation 105 2002 1240 1246 (Pubitemid 34225827)
3. H. Ashrafian, M.P. Frenneaux, and L.H. Opie Metabolic mechanisms in heart failure Circulation 116 2007 434 448 (Pubitemid 47196549)
4. M. Bazuine, K.G. Stenkula, M. Cam, M. Arroyo, and S.W. Cushman Guardian of corpulence: a hypothesis on p53 signaling in the fat cell Clin. Lipidol. 4 2009 231 243
5. V. Benoit, E. de Moraes, N.A. Dar, E. Taranchon, V. Bours, A. Hautefeuille, P. Tanire, A. Chariot, J.Y. Scoazec, and C.V. de Moura Gallo Transcriptional activation of cyclooxygenase-2 by tumor suppressor p53 requires nuclear factor-kappaB Oncogene 25 2006 5708 5718 (Pubitemid 44435248)
6. G.E. Demas, and T.J. Bartness Novel method for localized, functional sympathetic nervous system denervation of peripheral tissue using guanethidine J. Neurosci. Methods 112 2001 21 28 (Pubitemid 32964709)
7. M.Y. Donath, and S.E. Shoelson Type 2 diabetes as an inflammatory disease Nat. Rev. Immunol. 11 2011 98 107
8. M.G. Edwards, R.M. Anderson, M. Yuan, C.M. Kendziorski, R. Weindruch, and T.A. Prolla Gene expression profiling of aging reveals activation of a p53-mediated transcriptional program BMC Genomics 8 2007 80
9. J.S. Floras Sympathetic nervous system activation in human heart failure: clinical implications of an updated model J. Am. Coll. Cardiol. 54 2009 375 385
10. M.T. Foster, and T.J. Bartness Sympathetic but not sensory denervation stimulates white adipocyte proliferation Am. J. Physiol. Regul. Integr. Comp. Physiol. 291 2006 R1630 R1637
11. W. Guo, S. Wong, J. Pudney, R. Jasuja, N. Hua, L. Jiang, A. Miller, P.W. Hruz, J.A. Hamilton, and S. Bhasin Acipimox, an inhibitor of lipolysis, attenuates atherogenesis in LDLR-null mice treated with HIV protease inhibitor ritonavir Arterioscler. Thromb. Vasc. Biol. 29 2009 2028 2032
12. G. Haemmerle, A. Lass, R. Zimmermann, G. Gorkiewicz, C. Meyer, J. Rozman, G. Heldmaier, R. Maier, C. Theussl, and S. Eder Defective lipolysis and altered energy metabolism in mice lacking adipose triglyceride lipase Science 312 2006 734 737
13. M. Harada, Y. Qin, H. Takano, T. Minamino, Y. Zou, H. Toko, M. Ohtsuka, K. Matsuura, M. Sano, and J. Nishi G-CSF prevents cardiac remodeling after myocardial infarction by activating the Jak-Stat pathway in cardiomyocytes Nat. Med. 11 2005 305 311 (Pubitemid 40460559)
14. S.L. Harris, and A.J. Levine The p53 pathway: positive and negative feedback loops Oncogene 24 2005 2899 2908 (Pubitemid 40638098)
15. A. Hjalmarson, S. Goldstein, B. Fagerberg, H. Wedel, F. Waagstein, J. Kjekshus, J. Wikstrand, D. El Allaf, J. Vítovec, J. Aldershvile MERIT-HF Study Group Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF) JAMA 283 2000 1295 1302 (Pubitemid 30129796)
16. P.D. Home, S.J. Pocock, H. Beck-Nielsen, P.S. Curtis, R. Gomis, M. Hanefeld, N.P. Jones, M. Komajda, J.J. McMurray RECORD Study Team Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial Lancet 373 2009 2125 2135
17. G.S. Hotamisligil Inflammation and metabolic disorders Nature 444 2006 860 867 (Pubitemid 46024993)
18. G.S. Hotamisligil, N.S. Shargill, and B.M. Spiegelman Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance Science 259 1993 87 91 (Pubitemid 23036092)
19. G. Iaccarino, P.C. Dolber, R.J. Lefkowitz, and W.J. Koch Bbeta-adrenergic receptor kinase-1 levels in catecholamine-induced myocardial hypertrophy: regulation by beta- but not alpha1-adrenergic stimulation Hypertension 33 1999 396 401 (Pubitemid 29065691)
20. E. Ingelsson, J. Sundström, J. Arnlöv, B. Zethelius, and L. Lind Insulin resistance and risk of congestive heart failure JAMA 294 2005 334 341 (Pubitemid 41043777)
21. N. Kamei, K. Tobe, R. Suzuki, M. Ohsugi, T. Watanabe, N. Kubota, N. Ohtsuka-Kowatari, K. Kumagai, K. Sakamoto, and M. Kobayashi Overexpression of monocyte chemoattractant protein-1 in adipose tissues causes macrophage recruitment and insulin resistance J. Biol. Chem. 281 2006 26602 26614 (Pubitemid 44401869)
22. W.B. Kannel Incidence and epidemiology of heart failure Heart Fail. Rev. 5 2000 167 173
23. A. Kosteli, E. Sugaru, G. Haemmerle, J.F. Martin, J. Lei, R. Zechner, and A.W. Ferrante Jr. Weight loss and lipolysis promote a dynamic immune response in murine adipose tissue J. Clin. Invest. 120 2010 3466 3479
24. A. Leizorovicz, P. Lechat, M. Cucherat, and F. Bugnard Bisoprolol for the treatment of chronic heart failure: a meta-analysis on individual data of two placebo-controlled studies - CIBIS and CIBIS II. Cardiac Insufficiency Bisoprolol Study Am. Heart J. 143 2002 301 307
25. G.D. Lopaschuk, C.D. Folmes, and W.C. Stanley Cardiac energy metabolism in obesity Circ. Res. 101 2007 335 347 (Pubitemid 47267702)
26. B. Maier, W. Gluba, B. Bernier, T. Turner, K. Mohammad, T. Guise, A. Sutherland, M. Thorner, and H. Scrable Modulation of mammalian life span by the short isoform of p53 Genes Dev. 18 2004 306 319 (Pubitemid 38199255)
27. S. Marino, M. Vooijs, H. van Der Gulden, J. Jonkers, and A. Berns Induction of medulloblastomas in p53-null mutant mice by somatic inactivation of Rb in the external granular layer cells of the cerebellum Genes Dev. 14 2000 994 1004 (Pubitemid 30253007)
28. D.W. Meek Tumour suppression by p53: a role for the DNA damage response? Nat. Rev. Cancer 9 2009 714 723
29. T. Minamino, and I. Komuro Vascular cell senescence: contribution to atherosclerosis Circ. Res. 100 2007 15 26 (Pubitemid 46074968)
30. T. Minamino, and I. Komuro Vascular aging: insights from studies on cellular senescence, stem cell aging, and progeroid syndromes Nat. Clin. Pract. Cardiovasc. Med. 5 2008 637 648
31. T. Minamino, M. Orimo, I. Shimizu, T. Kunieda, M. Yokoyama, T. Ito, A. Nojima, A. Nabetani, Y. Oike, and H. Matsubara A crucial role for adipose tissue p53 in the regulation of insulin resistance Nat. Med. 15 2009 1082 1087
32. S. Nemoto, P. Razeghi, M. Ishiyama, G. De Freitas, H. Taegtmeyer, and B.A. Carabello PPAR-gamma agonist rosiglitazone ameliorates ventricular dysfunction in experimental chronic mitral regurgitation Am. J. Physiol. Heart Circ. Physiol. 288 2005 H77 H82
33. S. Neubauer The failing heart - an engine out of fuel N. Engl. J. Med. 356 2007 1140 1151 (Pubitemid 46425598)
34. L.A. Nikolaidis, A. Sturzu, C. Stolarski, D. Elahi, Y.T. Shen, and R.P. Shannon The development of myocardial insulin resistance in conscious dogs with advanced dilated cardiomyopathy Cardiovasc. Res. 61 2004 297 306 (Pubitemid 38091770)
35. L.H. Opie The metabolic vicious cycle in heart failure Lancet 364 2004 1733 1734 (Pubitemid 39488043)
36. N. Ouchi, J.L. Parker, J.J. Lugus, and K. Walsh Adipokines in inflammation and metabolic disease Nat. Rev. Immunol. 11 2011 85 97
37. M. Packer, A.J. Coats, M.B. Fowler, H.A. Katus, H. Krum, P. Mohacsi, J.L. Rouleau, M. Tendera, A. Castaigne, E.B. Roecker Carvedilol Prospective Randomized Cumulative Survival Study Group Effect of carvedilol on survival in severe chronic heart failure N. Engl. J. Med. 344 2001 1651 1658 (Pubitemid 32479962)
38. M. Packer, M.B. Fowler, E.B. Roecker, A.J. Coats, H.A. Katus, H. Krum, P. Mohacsi, J.L. Rouleau, M. Tendera, C. Staiger Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) Study Group Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study Circulation 106 2002 2194 2199 (Pubitemid 35222212)
39. P.A. Poole-Wilson, K. Swedberg, J.G. Cleland, A. Di Lenarda, P. Hanrath, M. Komajda, J. Lubsen, B. Lutiger, M. Metra, W.J. Remme Carvedilol Or Metoprolol European Trial Investigators Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial Lancet 362 2003 7 13 (Pubitemid 36835815)
40. J.A. Royds, and B. Iacopetta p53 and disease: when the guardian angel fails Cell Death Differ. 13 2006 1017 1026
41. K.M. Ryan, M.K. Ernst, N.R. Rice, and K.H. Vousden Role of NF-kappaB in p53-mediated programmed cell death Nature 404 2000 892 897 (Pubitemid 30230343)
42. M. Sano, T. Minamino, H. Toko, H. Miyauchi, M. Orimo, Y. Qin, H. Akazawa, K. Tateno, Y. Kayama, and M. Harada p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload Nature 446 2007 444 448 (Pubitemid 46474597)
43. S. Schenk, M. Saberi, and J.M. Olefsky Insulin sensitivity: modulation by nutrients and inflammation J. Clin. Invest. 118 2008 2992 3002
44. P. Schnabel, C. Maack, F. Mies, S. Tyroller, A. Scheer, and M. Böhm Binding properties of beta-blockers at recombinant beta1-, beta2-, and beta3-adrenoceptors J. Cardiovasc. Pharmacol. 36 2000 466 471
45. N. Sharma, I.C. Okere, M.K. Duda, D.J. Chess, K.M. O'Shea, and W.C. Stanley Potential impact of carbohydrate and fat intake on pathological left ventricular hypertrophy Cardiovasc. Res. 73 2007 257 268 (Pubitemid 44937701)
46. I. Shimizu, T. Minamino, H. Toko, S. Okada, H. Ikeda, N. Yasuda, K. Tateno, J. Moriya, M. Yokoyama, and A. Nojima Excessive cardiac insulin signaling exacerbates systolic dysfunction induced by pressure overload in rodents J. Clin. Invest. 120 2010 1506 1514
47. N. Suskin, R.S. McKelvie, R.J. Burns, R. Latini, D. Pericak, J. Probstfield, J.L. Rouleau, C. Sigouin, C.B. Solymoss, and R. Tsuyuki Glucose and insulin abnormalities relate to functional capacity in patients with congestive heart failure Eur. Heart J. 21 2000 1368 1375 (Pubitemid 30599132)
48. A. Tenenbaum, M. Motro, E.Z. Fisman, J. Leor, D. Freimark, V. Boyko, L. Mandelzweig, Y. Adler, Y. Sherer, and S. Behar Functional class in patients with heart failure is associated with the development of diabetes Am. J. Med. 114 2003 271 275 (Pubitemid 36398071)
49. C. Torp-Pedersen, M. Metra, A. Charlesworth, P. Spark, M.A. Lukas, P.A. Poole-Wilson, K. Swedberg, J.G. Cleland, A. Di Lenarda, W.J. Remme, A. Scherhag COMET investigators Effects of metoprolol and carvedilol on pre-existing and new onset diabetes in patients with chronic heart failure: data from the Carvedilol Or Metoprolol European Trial (COMET) Heart 93 2007 968 973 (Pubitemid 47122050)
50. H. Tuunanen, E. Engblom, A. Naum, K. Ngren, B. Hesse, K.E. Airaksinen, P. Nuutila, P. Iozzo, H. Ukkonen, L.H. Opie, and J. Knuuti Free fatty acid depletion acutely decreases cardiac work and efficiency in cardiomyopathic heart failure Circulation 114 2006 2130 2137 (Pubitemid 44747893)
51. S.D. Tyner, S. Venkatachalam, J. Choi, S. Jones, N. Ghebranious, H. Igelmann, X. Lu, G. Soron, B. Cooper, and C. Brayton p53 mutant mice that display early ageing-associated phenotypes Nature 415 2002 45 53 (Pubitemid 34062443)
52. K.H. Vousden, and D.P. Lane p53 in health and disease Nat. Rev. Mol. Cell Biol. 8 2007 275 283 (Pubitemid 46474662)
53. K.H. Vousden, and C. Prives Blinded by the Light: The Growing Complexity of p53 Cell 137 2009 413 431
54. K.H. Vousden, and K.M. Ryan p53 and metabolism Nat. Rev. Cancer 9 2009 691 700
55. S.P. Weisberg, D. McCann, M. Desai, M. Rosenbaum, R.L. Leibel, and A.W. Ferrante Jr. Obesity is associated with macrophage accumulation in adipose tissue J. Clin. Invest. 112 2003 1796 1808 (Pubitemid 38063703)
56. R.M. Witteles, and M.B. Fowler Insulin-resistant cardiomyopathy clinical evidence, mechanisms, and treatment options J. Am. Coll. Cardiol. 51 2008 93 102
57. M.E. Young, P. McNulty, and H. Taegtmeyer Adaptation and maladaptation of the heart in diabetes: Part II: potential mechanisms Circulation 105 2002 1861 1870 (Pubitemid 34408899)
58. L. Zeng, G.Z. Wu, K.J. Goh, Y.M. Lee, C.C. Ng, A.B. You, J. Wang, D. Jia, A. Hao, Q. Yu, and B. Li Saturated fatty acids modulate cell response to DNA damage: implication for their role in tumorigenesis PLoS ONE 3 2008 e2329